For overall survival (OS) and disease-specific survival (DSS), CD300E posed a risk factor in THCA, LUSC, LGG, LAML, KIRC, and GBM, while it acted as a protective factor only in SKCM (Figures 3A, B). This evidence concerns the gene CD300E and glioblastoma.